🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Christopher T. Chen

Stanford University

ORCID: 0000-0001-8911-0203

Biochemistry, Genetics and Molecular BiologyMedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Phase II trial of organ preservation program using short-course radiation and FOLFOXIRI for rectal cancer (SHORT-FOX): Two-Year primary outcome analysis”.

Phase II trial of organ preservation program using short-course radiation and FOLFOXIRI for rectal cancer (SHORT-FOX): Two-Year primary outcome analysis

Radiotherapy and Oncology(2025)10.1016/j.radonc.2025.110884

N/A

0.208DataRank · unranked

3 citations

Eleanor Brown, George A. Fisher, Andrew Shelton, T.P. Johnson, Shagufta Shaheen +18 more

Paving a pathway for drug development in HER2-positive biliary tract cancer

The Lancet Oncology(2021)10.1016/s1470-2045(21)00465-4

N/A

0DataRank · unranked

0 citations

Lipika Goyal, Christopher T. Chen

Targeting BRAF Class II and III Mutations in NSCLC with the pan-RAF inhibitor Exarafenib Reveals ARAF-KSR1-Mediated Resistance and Rational Combination Strategies

Research Square(2025)10.21203/rs.3.rs-5135027/v1

N/A

0DataRank · unranked

0 citations

Tadashi Manabe, Hannah C. Bergo, Qingtian Li, Tim Sen Wang, Paul Severson +19 more